To determine the clinical significance of PFKP Y64 phosphorylation-mediated HIF-1α expression, β-catenin S552 phosphorylation, and VEGF expression, we analyzed human primary GBM specimens through immunohistochemical (IHC) staining. The gene discussed is HIF1A; the disease is glioblastoma.